
Bonyf N.V (MLBON) | Financial Analysis & Statements
Bonyf N.V. | Small-cap | Healthcare
Bonyf N.V. | Small-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2021Income Metrics
Revenue
789.4K
Operating Income
789.4K
100.00%
Net Income
789.4K
100.00%
EPS (Diluted)
€1.34
Balance Sheet Metrics
Total Assets
1.7M
Total Liabilities
1.2M
Shareholders Equity
434.0K
Debt to Equity
2.87
Cash Flow Metrics
Operating Cash Flow
236.5K
Free Cash Flow
236.5K
Revenue & Profitability Trend
Bonyf N.V Income Statement From 2019 to 2024
Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 281.5K | 309.4K | 277.4K | 2.4M | 3.2M |
Cost of Goods Sold | 258.9K | 283.0K | 267.3K | 715.2K | 1.0M |
Gross Profit | 22.6K | 26.4K | 10.0K | 1.7M | 2.2M |
Gross Margin % | 8.0% | 8.5% | 3.6% | 69.9% | 67.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | 573.5K | 591.7K |
Other Operating Expenses | 3.1K | 10.6K | 221.5K | 68.9K | 105.4K |
Total Operating Expenses | 3.1K | 10.6K | 221.5K | 642.4K | 697.2K |
Operating Income | -34.7K | -39.9K | -317.5K | -48.8K | 226.0K |
Operating Margin % | -12.3% | -12.9% | -114.5% | -2.1% | 7.1% |
Non-Operating Items | |||||
Interest Income | 980 | 0 | - | 0 | 0 |
Interest Expense | 2.8K | 1.0M | 3.0M | 18.2K | 32.5K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -36.5K | -1.0M | -3.3M | -67.1K | 193.5K |
Income Tax | - | - | - | 3.1K | 2.8K |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 1.4% |
Net Income | -36.5K | -1.0M | -3.3M | -70.2K | 190.7K |
Net Margin % | -13.0% | -337.7% | -1,196.1% | -3.0% | 6.0% |
Key Metrics | |||||
EBITDA | -33.7K | -39.9K | -267.5K | 3.9K | 268.2K |
EPS (Basic) | - | - | €-5.64 | €-0.12 | €0.32 |
EPS (Diluted) | - | - | €-5.64 | €-0.12 | €0.32 |
Basic Shares Outstanding | - | - | - | 588600 | 588600 |
Diluted Shares Outstanding | - | - | - | 588600 | 588600 |
Income Statement Trend
Bonyf N.V Balance Sheet From 2019 to 2024
Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.0K | 10.0K | 393 | 50.5K | 38.8K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 64.2K | 35.0K | 129.8K | 134.4K | 114.2K |
Inventory | 19.9K | 37.3K | 23.8K | 499.3K | 422.3K |
Other Current Assets | - | - | - | 13.6K | 16.6K |
Total Current Assets | 340.9K | 92.9K | 170.6K | 1.1M | 1.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | 15.2K | 16.8K |
Goodwill | - | - | - | 78.1K | 90.6K |
Intangible Assets | - | - | - | 78.1K | 90.6K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 3.0M | 3.0M | 4.0M | 302.7K | 350.6K |
Total Assets | 3.3M | 3.1M | 4.2M | 1.4M | 1.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 311.7K | 299.6K | 364.7K | 228.4K | 242.4K |
Short-term Debt | 36.0K | 75.0K | 0 | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 306.1K | 12.8K | 2.0K | - | - |
Total Current Liabilities | 674.7K | 411.9K | 445.0K | 258.9K | 256.3K |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | 267.7K | 221.8K |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 21.8K | - | - | 573.0K | 563.1K |
Total Non-Current Liabilities | 21.8K | 0 | 0 | 840.6K | 785.0K |
Total Liabilities | 696.5K | 411.9K | 445.0K | 1.1M | 1.0M |
Equity | |||||
Common Stock | 7.1M | 7.1M | 7.1M | 293.5K | 289.5K |
Retained Earnings | -4.4M | -4.4M | -3.3M | -13.5K | 55.9K |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.6M | 2.7M | 3.7M | 280.1K | 345.5K |
Key Metrics | |||||
Total Debt | 36.0K | 75.0K | 0 | 267.7K | 221.8K |
Working Capital | -333.8K | -319.1K | -274.4K | 818.0K | 779.8K |
Balance Sheet Composition
Bonyf N.V Cash Flow Statement From 2020 to 2020
Metric | 2020 |
---|---|
Operating Activities | |
Net Income | - |
Depreciation & Amortization | - |
Stock-Based Compensation | - |
Working Capital Changes | 0 |
Operating Cash Flow | 57.0M |
Investing Activities | |
Capital Expenditures | - |
Acquisitions | - |
Investment Purchases | - |
Investment Sales | - |
Investing Cash Flow | - |
Financing Activities | |
Share Repurchases | - |
Dividends Paid | - |
Debt Issuance | - |
Debt Repayment | - |
Financing Cash Flow | - |
Free Cash Flow | 57.0M |
Net Change in Cash | 57.0M |
Cash Flow Trend
Bonyf N.V Key Financial Ratios
Valuation Ratios
Price to Book
17.50
Price to Sales
27.60
Profitability Ratios
Profit Margin
8.02%
Operating Margin
-11.98%
Return on Equity
-1.38%
Return on Assets
-1.09%
Financial Health
Current Ratio
4.92
Debt to Equity
0.00
Per Share Data
EPS (TTM)
€-1.78
Book Value per Share
€0.74
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
mlbon | 7.8M | - | 17.50 | -1.38% | 8.02% | 0.00 |
EssilorLuxottica | 123.5B | 51.90 | 3.26 | 6.44% | 8.74% | 36.58 |
Sartorius Stedim | 17.3B | 76.84 | 4.40 | 5.69% | 7.78% | 73.51 |
Crossject S.A | 85.4M | - | - | 478.68% | 0.00% | -7.88 |
Visiomed Group SA | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
Spineway S.A | 4.5M | 0.02 | 0.18 | -8.42% | -16.10% | 6.46 |
Financial data is updated regularly. All figures are in the company's reporting currency.